Safety and immune responses after vaccination with two investigational RNA-based vaccines against tuberculosis in healthy volunteers
Phase 1
- Conditions
- TuberculosisMedDRA version: 21.1Level: LLTClassification code: 10045023Term: Tuberculosis prophylaxis Class: 10042613MedDRA version: 21.1Level: PTClassification code: 10072084Term: Tuberculosis immunisation Class: 100000004865Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
- Registration Number
- CTIS2023-509515-89-00
- Lead Sponsor
- BioNTech SE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 128
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method